CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- 4 Planned sale Chief Commercial Officer sold 2,804 shares at $32.18 ($90,233)
- 8-K Event Regulation FD disclosure
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 200 shares at $46.28 ($9,256)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale Principal Accounting Officer sold 772 shares at $56.09 ($43,301)
- 4 Planned sale Director sold 20,000 shares at an average $55.86 ($1,117,147)
- 4 Planned sale Chief Legal Officer sold 21,752 shares at an average $52.21 ($1,135,775)
- 144 Insider Sale of Securities
- SC 13G/A Stake Amended Statement of Ownership
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale Chief Financial Officer sold 2,542 shares at $49.03 ($124,634)
- 4 Option exercise Director acquired 2,302 shares (option exercise)
- 4 Option exercise Director acquired 2,302 shares (option exercise)
- 4 Planned sale Chief Executive Officer sold 11,091 shares at $42.75 ($474,140)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
Page 10 of 66 · 1,304 filings